Kirk Szafranski
Kirk Szafranski publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics, on topics such as Diabetes Management and Research, Diabetes Management and Education and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #2,629,812 of 7,710,434 ranked researchers
- Rank in Canada
- #85,754 of 183,316
- Works
- 23
- Citations
- 397
- Citations per work
- 17.3
What does Kirk Szafranski research?
Kirk Szafranski's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (17%), Economics, Econometrics and Finance (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1043.8%
- Medicine1043.8%
- Everything else731.2%
- Life Sciences417.2%
- Social Sciences27.8%
- 1Endocrinology, Diabetes and Metabolism34% of their works
- 2Molecular Biology11% of their works
- 3Economics and Econometrics8% of their works
- 4Genetics6% of their works
- 5Epidemiology5% of their works
- 6Surgery5% of their works
Research topics
- Diabetes Management and Research
- Diabetes Management and Education
- Health Systems, Economic Evaluations, Quality of Life
- RNA Research and Splicing
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Virus-based gene therapy research
- Diabetes and associated disorders
Which keywords describe Kirk Szafranski's research?
The keywords of their largest research topics: Diabetes, Glycemic Control, Cardiovascular Disease, Insulin Therapy, Type 1 Diabetes, Continuous Glucose Monitoring, Depression and Hypoglycemia.
- Genetics
- Autoimmunity
- Metabolic Syndrome
- Hyperglycemia
- Alternative Splicing
- Cost-effectiveness Analysis
- Hypoglycemia
- Continuous Glucose Monitoring
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Disease
- Type 1 Diabetes
- Depression
- Self-Management
- Quality of Life
- Critical Care
- Insulin Resistance
- RNA-Binding Proteins
- Gene Therapy
- Viral Vectors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Diabetes193 topics
- Glycemic Control193 topics
- Cardiovascular Disease112 topics
- Insulin Therapy112 topics
- Type 1 Diabetes102 topics
- Continuous Glucose Monitoring81 topic
- Depression81 topic
- Hypoglycemia81 topic
- Self-Management81 topic
- Cost-effectiveness Analysis51 topic
- Quality of Life51 topic
- Alternative Splicing31 topic
- Critical Care31 topic
- Hyperglycemia31 topic
- Insulin Resistance31 topic
- Metabolic Syndrome31 topic
- RNA-Binding Proteins31 topic
- Autoimmunity21 topic
- Gene Therapy21 topic
- Genetics21 topic
- Viral Vectors21 topic
Where does Kirk Szafranski work?
Kirk Szafranski's main affiliation in the publication record is EVERSANA (Canada), Canada.
How many publications and citations does Kirk Szafranski have?
OpenAlex counts 23 works and 397 citations for Kirk Szafranski, an h-index of 10, ranking #2,629,812 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kirk Szafranski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.